TACKLING INDIA'S SICKLE CELL ANEMIA CHALLENGE
Healthcare Radius|July 2024
Sickle cell anemia (SCA), a hereditary red blood cell disorder, poses a serious public health challenge. Examine its prevalence, severity, and the steps that the healthcare sector needs to take.
TACKLING INDIA'S SICKLE CELL ANEMIA CHALLENGE

In the heart of India's diverse landscape, a silent but serious health threat looms large: sickle cell anemia (SCA). Across tribal communities and urban centers alike, its impact indicates the urgent need of 360-degree strategies to address it.

India accounts for 14.5 percent of newborns with sickle cell disease (SCD), estimated to be over 42,000 annually. The phenotype of SCD in India was considered mild due to factors like higher fetal hemoglobin levels or co-inheritance of alpha thalassemia. However, recent studies highlight the severity of the disease, especially among tribal populations. Before reaching the age of two, 20 percent of tribal children with SCD die, and 30 percent do not survive to adulthood.

SCD is caused by either homozygous inheritance of the hemoglobin S mutation (HBSS) or compound heterozygous inheritance of the hemoglobin S mutation with another ẞ-globin chain abnormality. India has one of the highest hemoglobin S allele frequencies globally, and the third-highest birth rate for babies born with HbSS. The beta-sickle globin mutation (BS) is particularly common among aboriginal tribal populations (Adivasis) and historically disadvantaged groups known as scheduled castes. An estimated 1 in 86 births in these populations results in sickle cell anemia.

Stating that the situation is alarming along the Narmada River belt, Mahanadi River belt, and the jungles of Odisha, Dr Dinesh Pendharkar, Director - Oncology, Cell and Gene Therapy and Bone Marrow Transplantation, Sarvodaya Hospital, Sector 8, Faridabad, informs, "There are approximately 100 districts with a high prevalence. The average number of patients in these ranges varied between 1,000 and 2,000.The total number in the country is approximately three-lakh. In Africa most sickle cell anemia patients die before five years of age. Our child mortality data are not available."

هذه القصة مأخوذة من طبعة July 2024 من Healthcare Radius.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

هذه القصة مأخوذة من طبعة July 2024 من Healthcare Radius.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

المزيد من القصص من HEALTHCARE RADIUS مشاهدة الكل
KIMSHEALTH launches electrophysiology lab with 3D mapping
Healthcare Radius

KIMSHEALTH launches electrophysiology lab with 3D mapping

'ENSITE X' is the first of its kind in Kerala and the third in India enabling precise identification, mapping, and targeting the abnormal electrical activities in the heart.

time-read
1 min  |
November 2024
Molbio boosts Goa's healthcare system with CSR initiatives
Healthcare Radius

Molbio boosts Goa's healthcare system with CSR initiatives

The company has donated four state-of-the-art Advanced Life Support (ALS) ambulances and two hearse vans for National Highway emergencies

time-read
1 min  |
November 2024
USV introduces affordable heart failure medication
Healthcare Radius

USV introduces affordable heart failure medication

This cost-effective option addresses the rising cases of heart failure in India, offering lifesaving care to millions of patients who need it the most.

time-read
1 min  |
November 2024
City Imaging & Clinical Labs to expand services to 50 hospitals
Healthcare Radius

City Imaging & Clinical Labs to expand services to 50 hospitals

The company is currently associated with 10 hospitals, providing comprehensive lab management services, including 24/7 in-house phlebotomy and lab testing.

time-read
1 min  |
November 2024
Oncare raises $1 million in seed funding, to set up 10 units
Healthcare Radius

Oncare raises $1 million in seed funding, to set up 10 units

Oncare has raised $1 million in a seed funding round led by Huddle Ventures. It plans to deploy the raised capital to expand its operations to 10 new centers.

time-read
1 min  |
November 2024
Nutrabay forays into Ayurvedic supplements market with Shilajit
Healthcare Radius

Nutrabay forays into Ayurvedic supplements market with Shilajit

Nutrabay's aims at gaining market share from the existing ayurveda supplements market with a distinctive product proposition and education about the benefits of Shilajit.

time-read
1 min  |
November 2024
INDIA'S PREPAREDNESS ON HEALTHCARE-ASSOCIATED INFECTIONS: A GROWING FOCUS ON PATIENT SAFETY
Healthcare Radius

INDIA'S PREPAREDNESS ON HEALTHCARE-ASSOCIATED INFECTIONS: A GROWING FOCUS ON PATIENT SAFETY

The country's diverse healthcare landscape necessitates a flexible and multifaceted approach to infection control that can be adapted to various settings and resource levels.

time-read
8 mins  |
November 2024
TRANSFORMING CARDIAC SURGERY: HOW AI IS REVOLUTIONIZING PATIENT CARE AND OUTCOMES
Healthcare Radius

TRANSFORMING CARDIAC SURGERY: HOW AI IS REVOLUTIONIZING PATIENT CARE AND OUTCOMES

Dr. Swarup Swaraj Pal shared his insights on the current state and future prospects of AI in cardiac procedures.

time-read
3 mins  |
November 2024
BEYOND THE LAB: THE CRITICAL ROLE OF LOGISTICS IN INDIA'S PHARMACEUTICAL INDUSTRY
Healthcare Radius

BEYOND THE LAB: THE CRITICAL ROLE OF LOGISTICS IN INDIA'S PHARMACEUTICAL INDUSTRY

As India continues to expand its role in the global pharmaceutical market, the importance of a robust, reliable, and innovative logistics infrastructure cannot be overstated.

time-read
8 mins  |
November 2024
LIFESTYLE DISEASES IN CHILDREN: A WAKE-UP CALL FOR A HEALTHIER GENERATION
Healthcare Radius

LIFESTYLE DISEASES IN CHILDREN: A WAKE-UP CALL FOR A HEALTHIER GENERATION

In today's fast-paced world, children face an unexpected enemy: lifestyle diseases. Conditions like obesity, Type 2 diabetes, and hypertension are now affecting our youth. What's causing this shift, and how can we combat it?

time-read
3 mins  |
November 2024